DOSSIER · 13F-HR · Q3 2026

Rhenman & Partners Asset Management AB

$903M in tracked AUM across 93 positions as of Q3 2026.

R&
CIK 0001599882 · last filed Sep 30, 2026
Total AUM
$903M
as of Q3 2026
Holdings
93
—
positions
Whale Score
56
56
tracked
Activity
—
no data
changes this Q
AI Analysis · Q3 2026

Rhenman & Partners Asset Management AB filed its latest 13F-HR for Q3 2026. See the latest holdings and position changes below.

Quarter at a glance — Q3 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q3 2026. Source: SEC EDGAR 13F-HR filings.

#HoldingValueSharesWeight
01
IOVA
IOVANCE BIOTHERAPEUTICS INC
$37M2.5M4.1%
02
G0593M107
ASTRAZENECA PLC
$30M185K3.4%
03
MRK
MERCK & CO. INC
$30M207K3.3%
04
G5960L103
MEDTRONIC PLC
$29M340K3.2%
05
UNH
UNITEDHEALTH GROUP INC
$26M71K2.9%
06
VRTX
VERTEX PHARMACEUTICALS INC
$26M49K2.8%
07
GILD
GILEAD SCIENCES INC
$24M159K2.6%
08
EW
EDWARDS LIFESCIENCES CORP
$24M273K2.6%
09
BMRN
BIOMARIN PHARMACEUTICAL INC
$23M387K2.6%
10
BIIB
BIOGEN INC
$22M97K2.4%

Filing history

2026Q3Sep 30
$903M▼ 14.8%
93 positionsView →
2026Q2Jun 30
$1.1B▲ 30.7%
99 positionsView →
2026Q1Mar 31
$810M▼ 24.3%
86 positionsView →
2025Q4Dec 31
$1.1B▲ 110.6%
94 positionsView →
2025Q3Sep 30
$508M▼ 35.8%
60 positionsLocked
2025Q2Jun 30
$791M▲ 61.0%
90 positionsLocked
2025Q1Mar 31
$491M▼ 49.5%
59 positionsLocked
2024Q4Dec 31
$973M▼ 21.0%
92 positionsLocked
2024Q3Sep 30
$1.2B▲ 18.3%
95 positionsLocked
2024Q2Jun 30
$1.0B▼ 1.3%
93 positionsLocked
2024Q1Mar 31
$1.1B▲ 5.4%
84 positionsLocked
2023Q4Dec 31
$1.0B▲ 7.8%
85 positionsLocked
Showing 12 of 46